advertisementsupport byth activ ingredi ketamin popular club drug show promis battl deep benedict careyin move may clear way first new treatment year depress expert panel recommend tuesday feder regul approv nasal spray deliv activ ingredi ketamin popular club drug new drug call esketamin develop johnson johnson aim peopl sever depress particularli suicid think the panel vote member includ psychiatrist consum repres nearli unanim decid drug benefit outweigh risk the food drug administr typic follow recommend expert recent year score clinic open around countri offer administ intraven ketamin depress schedul similar electroshock therapi seri treatment period day week sometim includ booster visit month later these treatment averag cost offici usual cover insur their effect well studi although peopl receiv cours treatment report rapid alway last approv esketamin would cover insur like scienc time page facebook sign scienc time newslett the interest ketamin potenti treatment date back research nation institut mental health led carlo zarat report peopl receiv drug intraven report despair lift within hour the drug current market depress typic take two week provid notic relief discoveri ketamin effect depress serendipit underli biolog disord remain unknown some research sinc turn away investig serotonin brain transmitt popular antidepress work instead studi effect ketamin brain chemistri see drug provid clue biolog depress the feder agenc march decid whether approv drug brook johnson piano teacher westminst wait approv month johnson marri daughter know esketamin help said exist antidepress fail she said psychiatr hospit six time attempt suicid it back forth relaps put back johnson said interview last month none medicin ever seem work at best would either numb complet feel noth need altern treatment soon possibl said 